CBD oil for breast cancer before surgery
Treatments studied
Part of Cancer, Skin clinical trials.
This trial tests if taking CBD oil before surgery can help treat invasive breast cancer. It is for women with fast-growing tumors who are scheduled for surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have invasive breast cancer (stage I, II, or III) and your tumor has a Ki67 score of 10% or higher.
- You are a woman age 18 or older.
- You are able to have surgery, and your surgery is planned between 5 and 56 days after starting the study drug.
- You are not pregnant or breastfeeding, and if you could become pregnant, you agree to use birth control.
- You have good organ and blood function as shown by recent lab tests.
- You are not taking certain medications like blood thinners, some antidepressants, or drugs that interact with CBD.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests giving chemotherapy before surgery to shrink breast tumors, which may make surgery easier or allow breast-conserving options. It is for adults with invasive breast cancer that has not spread to distant organs.
This study tests combining chemotherapy before surgery with radiation therapy before surgery for locally advanced breast cancer. The goal is to see if this approach can improve outcomes, especially for patients whose tumors didn't shrink enough with initial chemo.
This trial tests whether giving chemotherapy before surgery, guided by the genetic profile of your tumor, can improve outcomes for a specific type of HER2-positive breast cancer. It aims to tailor treatment to each person's cancer biology.
This trial tests a new drug, QL1706, given alongside chemotherapy before surgery for a certain type of breast cancer. It aims to see if this combination helps shrink tumors before they are removed.
This trial is testing how well a short course of hormone-blocking pills (endocrine therapy) works before surgery in women with early-stage hormone receptor-positive HER2-negative breast cancer. The goal is to understand what makes some cancers resistant to these treatments.
This trial tests a treatment given before breast surgery to shrink breast cancer and improve outcomes based on your tumor type. Your eligibility depends on tumor size/stage, hormone and HER2 markers, and overall health checks.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.